Spotlight Innovation was founded in 2011 to commercialize intellectual property developed at major academic institutions. It identifies categories of IP with growth potential and implements processes to efficiently commercialize innovations. Currently, it has an agreement with a midwestern university giving it preferential review of the university's IP portfolio. Spotlight is forming an IP fund to allow investors to select patents covering life sciences and other technologies to incubate into startups. Its initial portfolio focuses on cancer, macular degeneration, and drug delivery patents from its partner university.

1. INTELLECTUAL PROPERTY (IP)
intellectual property . noun . property that results from original creative thought, as patents,
copyright material, and trademarks.
THE COMPANY
Spotlight Innovation, LLC was founded in mid-2011 to identify, validate and commercialize
healthcare-focused intellectual property developed by major centers of academia in the
United States. The principals of Spotlight Innovation have been involved in all stages of the
commercialization of healthcare IP developed by some of the nation’s premiere research and
development institutions. The company utilizes the skills of an extensive network of business
professionals, each seasoned in areas of expertise including financial, technical, marketing
and legal.
HOW WE DO BUSINESS
Spotlight combines innovative thinking with the proven ability to:
• identify categories of IP that have the attributes of future growth, scalability
and profit potential
• time entry into each category based on technological and cultural readiness
• identify and overcome barriers to successful commercialization and adoption
• implement repeatable processes that bring speed, accuracy and efficiency to
commercialization
A CONFLUENCE OF FACTORS = OPPORTUNITY
Three conditions now exist that, taken together, represent enormous opportunity for
Spotlight Innovation:
• Strong support of high levels of Federal funding for life sciences R&D continues to be a
priority for the Administration
• Academia has committed itself to supporting the President’s goal of strengthening
commercialization of the nearly $148 billion in annual federally-funded research and
development
• The Federal government is taking concrete steps to support the re-invigorated mission
of tech transfer from academia to the marketplace

2. STRENGTHENING TECHNOLOGY TRANSFER
CAPABILITIES
In coordination with the Obama PROFITS &
LAB TAX REVENUE
Administration, 135 University
presidents committed in September METHODS
JOBS
2011 to working more closely with
PROCESSES
LICENSE ISSUED SERVICES
PRODUCTS START UP COMPANY
industry, investors, and agencies to PROTECT IP SMALL COMPANY
bolster entrepreneurship, encourage
University-industry collaboration,
DISCLOSURE TO LARGE COMPANY PRODUCTS &
and advance the nation’s social and IDEA
PATENT OR COPYRIGHT
SERVICES
economic interests.
IP COLLABORATIVE AGREEMENT
Spotlight Innovation has secured an agreement with a leading mid-west University that
allows Spotlight Innovation and its Fund investors a preferential IP portfolio review and
selection process. We believe that this unique review and selection process will yield the
best possible outcomes for investors. Spotlight Innovation intends to enter into similar
agreements with other mid-west academic institutions.
Preemptive Advantage Investor Review Privilege
Spotlight Innovation and our Fund The Investor Review Privilege grants Spotlight
investors have a Preemptive Advantage with Innovation and our Fund investors a 60
the entire institutional IP portfolio of our day review period for all of our partner
partner institution. Our partner institution University’s 140 patented pieces of intellectual
will work only with Spotlight Innovation on property. The Investor Review Privilege allows
a targeted piece of IP. This is the strongest investors to select, remove, and customize
existing IP development agreement within the IP portfolio, in conjunction with Spotlight
this University. As with most closed-end Innovation, creating a closed-end fund to their
funds, investors will have final decision on exact specifications.
IP selection.
Spotlight seeks to increase the University’s IP ROI by engaging inventors, external
business professionals and the University itself in our proven business development and
commercialization processes, while ultimately positively impacting healthcare and patient
outcomes.
Spotlight Innovation is currently in active discussions with additional Universities to enter
into collaborative agreements.

3. THE IP FUND
The purpose of an IP fund is to provide strategic partners and investors with the opportunity
to participate in the financing of an investor preferred search for, acquisition of, and
commercialization of intellectual property. IP Funds have been in existence in earnest as an
asset class since 1997 and have been structured to provide scale and professional acumen to
invest strategically and broker it across technology domains.
The structure of the Fund will allow investors to select patents covering life sciences and
other technology within a custom IP Fund portfolio of their choice. True to the overall
business model, the Fund will incubate start-ups from acquisition to exit utilizing the IP.
The Fund is managed by a team with expertise in IP assessment, valuation, management,
business development and enforcement.
SELECTED IP
The intellectual property that Spotlight Innovation has selected as the launch portfolio is
diversified across three healthcare sectors: Cancer; Macular Degeneration; and Drug Delivery.
Within our partner University’s portfolio, these sectors have multiple pieces of IP that could
potentially be vertically integrated into one company per sector.
REGIONAL FOCUS
Spotlight Innovation intends to
concentrate its IP identification and
development efforts within the states
of Iowa, Illinois, Indiana, Kansas,
Minnesota, Missouri, Nebraska, Ohio,
South Dakota and Wisconsin.
Spotlight Innovation will connect with
Universities within this geographic area,
placing special emphasis on second-
tier research schools and schools in
smaller markets. The majority of these
institutions have an Office of Intellectual
Property (OIP).
CONTACT
Cris Grunewald
515-669-1215
Cris@SpotlightInnovation.com